We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNET
726
VNET Group
VNET
$2.09B
$2.38M 0.01%
+244,922
New +$1.74M
SB icon
727
Safe Bulkers
SB
$774M
$2.35M 0.01%
689,816
+601,288
+679% +$2M
RDN icon
728
Radian Group
RDN
$4.93B
$2.34M 0.01%
+144,265
New +$2.36M
CTRL
729
DELISTED
Control4 Corporation
CTRL
$2.33M 0.01%
+95,966
New +$2.24M
MCS icon
730
Marcus Corp
MCS
$945M
$2.33M 0.01%
71,696
-74,956
-51% -$2.36M
OKE icon
731
Oneok
OKE
$54.5B
$2.3M 0.01%
32,870
-105,812
-76% -$6.81M
YEXT icon
732
Yext
YEXT
$574M
$2.29M 0.01%
118,331
+41,193
+53% +$632K
VERI icon
733
Veritone
VERI
$122M
$2.29M 0.01%
+135,964
New +$2.65M
MTG icon
734
MGIC Investment
MTG
$6.25B
$2.28M 0.01%
212,844
-54,212
-20% -$590K
ACLS icon
735
Axcelis
ACLS
$4.33B
$2.27M 0.01%
+114,795
New +$2.52M
ELV icon
736
Elevance Health
ELV
$85.5B
$2.26M 0.01%
9,509
-288
-3% -$66.7K
BTI icon
737
British American Tobacco
BTI
$128B
$2.26M 0.01%
44,748
-231,402
-84% -$12.2M
NXTM
738
DELISTED
NxStage Medical Inc.
NXTM
$2.24M 0.01%
80,372
+64,889
+419% +$1.74M
MAS icon
739
Masco
MAS
$15.3B
$2.19M 0.01%
58,566
-25,164
-30% -$969K
OXSQ icon
740
Oxford Square Capital
OXSQ
$157M
$2.19M 0.01%
316,839
-135,843
-30% -$900K
ABAX
741
DELISTED
Abaxis Inc
ABAX
$2.19M 0.01%
+26,325
New +$2.02M
EVOP
742
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$2.17M 0.01%
+105,679
New +$2.22M
EXP icon
743
Eagle Materials
EXP
$6.57B
$2.17M 0.01%
20,639
-36,866
-64% -$3.88M
GGAL icon
744
Galicia Financial Group
GGAL
$7.42B
$2.17M 0.01%
+65,635
New +$3.38M
GSK icon
745
GSK
GSK
$106B
$2.16M 0.01%
42,862
-373,700
-90% -$18.8M
HOLI
746
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$2.15M 0.01%
+97,120
New +$2.28M
BMS
747
DELISTED
Bemis
BMS
$2.15M 0.01%
50,806
-46,893
-48% -$2.02M
BJ icon
748
BJs Wholesale Club
BJ
$12.3B
$2.14M 0.01%
+90,479
New +$2.07M
CPAY icon
749
Corpay
CPAY
$25.7B
$2.14M 0.01%
10,146
-37,240
-79% -$7.64M
OFG icon
750
OFG Bancorp
OFG
$2.21B
$2.14M 0.01%
152,037
-99,865
-40% -$1.35M
28 29
30
31 32

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.